Report: Cubs haven’t closed the door on Austin Jackson

SHARE Report: Cubs haven’t closed the door on Austin Jackson
Screen_Shot_2016_02_22_at_11.40.37_PM.jpg

According to a report from the Boston Globe, the Cubs – along with the Red Sox – are two teams that haven’t closed the door on signing the 29-year-old outfielder.

Jackson came to Chicago in a midseason trade last year and made an impact with the team, making 79 plate appearances in 29 games. He batted .267 last year in 136 games with the Cubs and Mariners.

Chicago appears to be set in the outfield with Kyle Schwarber in left, Jason Heyward in center and Jorge Soler in right, but a little bit more depth never hurts. As of right now, Chris Coghlan and Javier Baez figure to be the primary backups.

[nicelink url=”http://chicago.suntimes.com/baseball/7/71/1330934/javier-baez-working-outfielder-spring-training”]

But Schwarber will likely get some time at catcher and not everyone is sold on Heyward in center field, so Jackson (still an above-average defender who can play all three outfield positions) might be able to provide a little insurance.

The Indians are also reportedly interested in Jackson, who previously signed a one-year deal worth more than $7 million with Seattle back in 2015.

Cubs pitchers and catchers report to spring training

Stats via Baseball-Reference

The Latest
In each case, a black Kia SUV pulled up and a gunman gun out and demanded victims’ property.
Javonni Jenkins, 27, and Curtis Hartman, 79, were found Wednesday morning in their apartment. The 2-year-old did not appear to be injured but was taken to a hospital to be checked.
The singer revealed the diagnosis of the incurable neurological disorder in an emotional Instagram video Thursday adding that the symptoms are what have been causing her to have severe muscle spasms in the past.
The swap, at a time of heightened tensions over Ukraine, achieved a top goal for President Joe Biden, but carried a heavy price — and left behind an American jailed for nearly four years in Russia.
Unlike traditional treatments, which can only ease the effects of the disease, CAR T-cell therapy hints at a path to remission, though that’s based on a very small study.